A New CNS Cancer Treatment Playbook In The Making?

Add as your preferred news source on Google

Add Now

Beginning in August 2026, this healthcare company focused on central nervous system (CNS) cancers will adopt a new name, following months of planning that reflect its evolution into an integrated CNS oncology platform.

The company we are profiling today is Plus Therapeutics Inc. (PSTV), which will officially rebrand as Cerenome and begin trading under the new ticker symbol CNSY, effective August 3, 2026.

This article is available exclusively to RTT Biotech Investor and Intelligent Investor subscribers. Subscribe with a RTTNews subscription.

Start Free Trial

FREE 7-Day Trial - No Payment Required

Already subscribed? Sign in

For comments and feedback contact: editorial@rttnews.com

Business News

Plus Therapeutics Inc. (PSTV) will rebrand as Cerenome and change its ticker symbol to CNSY on August 3, 2026. This name change reflects the company's evolution into an integrated central nervous system oncology platform.